• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Replacement of infusion sets every seven days may be safe and cost-effective to prevent life-threatening catheter-related bloodstream infections

byNeel MistryandTeddy Guo
June 25, 2021
in Infectious Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Prevalence of catheter-related bloodstream infections (CRBSI) was similar in the intervention (7-day) and control (4-day) groups for central venous access devices (1.78% vs. 1.46%).

2. Compared to the 4-day group, the 7-day group had mean cost savings of AU$483 for central venous access devices and AU$43 for peripheral arterial catheters.

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Catheter-related bloodstream infection (CRBSI) accounts for 70% of all healthcare-related bloodstream infections. While studies suggest the optimal time interval for infusion set replacement to be four days, such a duration can have both financial and logistical limitations. This randomized controlled trial aimed to compare the effectiveness and costs of 7-day (intervention) versus 4-day (control) infusion set replacement to prevent life-threatening CRBSI in patients with central venous access devices and peripheral arterial catheters. The primary outcome was CRBSI, defined as bacteremia or fungemia and at least one positive blood culture plus matching organism(s) found on the catheter tip. Secondary outcomes included catheter tip colonization (>15 CFUs), infusion set colonization (≥103 CFU/mL) and all-cause bloodstream infection. According to study results, the proportion of patients with CRBSI in the 7-day group and 4-day group was similar, with no treatment-related adverse events. 7-day replacement was also associated with reduced consumable costs and staff time spent per patient. This study was limited by a lack of blinding between patients and clinical staff which may have introduced bias in the results. Nonetheless, this study provided valuable insight into 7-day versus 4-day infusion set replacement for the prevention of CRBSI.

Click to read the study in The Lancet

Relevant Reading: Comparison of Rates of Central Line–Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters

In-depth [randomized controlled trial]: Between May 30, 2011, and Dec 9, 2016, 6007 patients were assessed across 10 Australian hospitals. Included patients were of any age, with a central venous access device or peripheral arterial catheter for ≥ 24 hours and infusion sets attached. Those with a bloodstream infection in the past 48 hours or with infusion sets replaced were excluded. Altogether, 2944 patients (1463 in the 7-day group and 1481 in the 4-day group) were included in the modified intention-to-treat analysis.

RELATED REPORTS

Enteral glutamine does not reduce the time to discharge for severe burns

Totally implanted ports show reduced complication rates compared to other central venous access devices

Study highlights characteristics of pediatric ambulatory central line associated bacterial infections

The primary outcome of CRBSI was observed in 20 (1.78%) patients in the 7-day group and 16 (1.46%) in the 4-day group for central venous access devices (CVADs, absolute risk difference [ARD] 0.32%, 95% confidence interval [CI] -0.73 to 1.37). Findings between both groups were similar for CRBSI per 1000 days (1.36 for 7-day group vs. 1.08 for 4-day group, hazard ratio [HR] 1.33, 95% CI 0.69 to 2.57, p=0.40) and time to CRBSI. For peripheral arterial catheters (PACs), 1 (0.28%) patient in the 7-day group and 0 in the 4-day group had a CRBSI (ARD 0.28%, 95% CI -0.27 to 0.83). The secondary outcomes of catheter tip colonization, mortality, all-cause bloodstream infection, and central line-associated bloodstream infection showed no significant difference for CVADs and PACs. Furthermore, relative to the 4-day group, the 7-day group had mean cost savings of AU$483 (CVAD) and AU$43 (PAC). Similarly, the median nursing time saved with 7-day infusion set replacement was 174 min (CVAD) and 7 min (PAC). There were no treatment-related adverse events. Overall, findings from this study suggest that infusion set use can be safely extended to 7 days with resultant cost and workload reductions.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bacteremiabloodstream infectioncatheter-related bloodstream infectioncatheter-related bloodstream infection (CRBSI)central venous access devicefungemiainfusion set replacementperipheral arterial catheter
Previous Post

Microbiota-directed food intervention showed benefits for undernourished children

Next Post

#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events

RelatedReports

Patient transfers to trauma centers often unnecessary
Dermatology

Enteral glutamine does not reduce the time to discharge for severe burns

September 16, 2022
Surgical site anesthetic infusion may enhance analgesia after mastectomy
Chronic Disease

Totally implanted ports show reduced complication rates compared to other central venous access devices

August 10, 2021
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Study highlights characteristics of pediatric ambulatory central line associated bacterial infections

December 18, 2020
Racial, ethnic differences in outcomes of extremely preterm infants decreasing but persistent
Infectious Disease

Wide variability in rate of antibiotic exposure among infants in NICU

October 22, 2019
Next Post
#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events

#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events

Comprehensive geriatric assessment in primary care associated with reduced need for hospitalization in elderly

Vegetarian diet may lower incidence of colorectal cancer

Health literacy intervention for childhood obesity prevention has limited effects 

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Addition of fludrocortisone to hydrocortisone is beneficial in management of septic shock
  • Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
  • Childhood maltreatment may cause mental health problems
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options